Status:
COMPLETED
Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Lassa Virus Infection
Eligibility:
All Genders
6+ years
Brief Summary
Background: \- Lassa fever is very similar to other diseases that cause fever, such as malaria and yellow fever. People get Lassa fever from mice. A person can get Lassa fever from mice urine and dro...
Detailed Description
Throughout West Africa as many as 300,000 people are infected annually with Lassa virus, resulting in approximately 5,000 deaths. Most commonly, contact with infected rodent hosts (Mastomys natalensis...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age greater than or equal to 6 months.
- Resident of Soromba, Bamba or Banzana with no plans to relocate within 1 year.
- EXCLUSION CRITERIA:
- Any condition that in the opinion of the investigator would render the participant unable to comply with the protocol (e.g., psychiatric disease).
- Any health condition that would confound data analysis or pose unnecessary exposure risks to study personnel in the opinion of the investigator.
Exclusion
Key Trial Info
Start Date :
December 5 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 22 2018
Estimated Enrollment :
601 Patients enrolled
Trial Details
Trial ID
NCT02311387
Start Date
December 5 2014
End Date
October 22 2018
Last Update
December 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malaria Research and Training Center
Bamako, Mali